Many practicing radiologists share the general public’s sense of befuddlement over state-level breast density legislation and its implications for patient care, at least in New England, according to a study published online May 8 in Academic Radiology.

The 2017 Defense Appropriations Bill greenlighted by the Senate last week includes a $10 billion increase, to $90 billion, for the Pentagon’s prostate cancer research program.

Posttraumatic epilepsy is a known risk for adults who have suffered mild traumatic brain injury (MTBI). The same risk exists for children and teens, according to a longitudinal study published online May 5 in the Journal of Neurosurgery: Pediatrics.

A leader of the Washington, D.C.-based Black Women’s Health Imperative published an op-ed over the weekend urging passage of a bill in Texas that would require all commercial payers in the Lone Star State to cover digital breast tomosynthesis. 

Time recently published an article detailing a study from a team of Chinese and European researchers that found insomnia affects regions of the brain that regulate cognition, emotion and sensory processes. 

Point-of-care clinical decision support (CDS) has showcased its ability to safely head off unnecessary imaging of patients presenting with low back pain—the poster-child condition of overutilization and defensive medicine—in the busy emergency department of an urban academic medical center.

Liver cancer may face a formidable new adversary in the form of a novel MRI contrast agent that, in preclinical experiments, has shown its ability to wring clear tumor images from both T1- and T2-weighted MRI scans.

In what they’re calling the first molecular drug-imaging study in children, Dutch researchers have shown that PET/CT can help quantify performance of the cancer drug bevacizumab (trade name Avastin) inside pediatric brain tumors.